Stiolto Respimat 2.736 ug/1 (Tiotropium Bromide and Olodaterol SPRAY, METERED) 2.736 ug/1

Stiolto Respimat 2.736 µg/1 is a combination inhaler containing tiotropium bromide and olodaterol. It is designed for respiratory use to help manage chronic obstructive pulmonary disease (COPD) symptoms. This metered spray delivers precise doses for effective inhalation therapy.

Strength

2.736 ug/1

Pack Size

1 CARTRIDGE in 1 CARTON (0597-0155-70) / 10 SPRAY, METERED in 1 CARTRIDGE

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Stiolto Respimat 2.736 µg/1 is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It combines two active ingredients, tiotropium bromide and olodaterol, to help improve lung function and reduce symptoms such as wheezing, shortness of breath, and coughing. This medication is often prescribed for individuals with COPD to enhance breathing and overall respiratory health.

Side Effects

Common effects of Stiolto Respimat 2.736 µg/1 may include improved breathing and reduced symptoms of COPD. Some users might experience side effects such as dry mouth, throat irritation, or headaches. It is important to follow the prescribed usage guidelines to minimize potential adverse effects.

Precautions & Warnings

Stiolto Respimat 2.736 µg/1 should be used as directed by a healthcare professional. It is important to store the inhaler properly and keep it out of reach of children. Users should be aware of potential allergies to the ingredients and consult a healthcare provider if any severe reactions occur.

Avoid Interactions

Stiolto Respimat 2.736 µg/1 may interact with other medications, including beta-blockers, anticholinergics, and certain antidepressants. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, alcohol consumption should be moderated while using this inhaler.

Frequently Asked Questions

Stiolto Respimat 2.736 µg/1 is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) to improve lung function and reduce symptoms.

Stiolto Respimat 2.736 µg/1 is administered via inhalation using the provided metered spray device. Follow the instructions provided by your healthcare professional for proper use.

Common side effects may include dry mouth, throat irritation, and headaches. Consult your healthcare provider if you experience severe or persistent side effects.

Stiolto Respimat 2.736 µg/1 may interact with other medications, so it is important to inform your healthcare provider about all medications you are taking.

Store Stiolto Respimat 2.736 µg/1 in a cool, dry place away from direct sunlight and out of reach of children.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.